Overall, TRAF2 was shown to positively correlate with the expression of genes associated with immune checkpoints in most cancer types (Figure 7A), which supports the hypothesis that TRAF2 may be effective in cancer immunotherapy. The gene discussed is TRAF2; the disease is cancer.